Efficacy and safety of temelimab in multiple sclerosis: Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study

Hans Peter Hartung, Tobias Derfuss, Bruce A.C. Cree, Maria Pia Sormani, Krzysztof Selmaj, Jonathan Stutters, Ferran Prados, David MacManus, Hans Martin Schneble, Estelle Lambert, Hervé Porchet, Robert Glanzman, David Warne, Francois Curtin, Gabrielle Kornmann, Bénédicte Buffet, David Kremer, Patrick Küry, David Leppert, Thomas RückleFrederik Barkhof

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of temelimab in multiple sclerosis: Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study'. Together they form a unique fingerprint.

Medicine & Life Sciences